Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Three Amigos Stock Thread -- Ignore unavailable to you. Want to Upgrade?

To: Steve Felix who wrote (18079)	12/27/1999 5:40:00 PM
From: Sergio H	Read Replies (2) \| Respond to of 29382

Steve, I also like IMGN. Nice chart and fundamentals are improving. Like several other pharmaceutical companies, it could get a real big push from expected news and developments. SmithKline Beecham and BioChem Pharma relationships are a big plus. DFCO, I don't see anything shaking this one up. Interesting niche. I wonder if they supply National Geographic. INKP target is easy :-) 3 1/4 before news. After that.... Thanks for bringing it to the thread. WWES - nothing happening until it gets over 2 1/16 - 2 1/8. Convergence of moving avgs. should occur soon. We'll have to alert Myron. Sergio

To: Steve Felix who wrote (18079)	12/27/1999 7:03:00 PM
From: Ken W	Read Replies (1) \| Respond to of 29382

Steve, "anybody good with targets" INKP: As I'm sure you know the highs for the stock have been in the 3 area. Unless the news is stellar that is where the stock will stall for a while. If the 3 area is broken on great volume then INKP has no real limit as far as how high it will go. We have seen other stocks make moves into the 20's from the single digits. BAMM, GRIN etc. Personally, I have one problem with INKP. Since it has doubled in the last 52 weeks rather than form a year long base the possibility of huge gains will be limited. Kind of in the same boat as IFLO. BTW I own both, now! Ken